Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
Zhuoying Huang, Shuangfei Xu, Jiechen Liu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 78
Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms — China, December 2022–February 2023
Di Fu, Guanhao He, Huanlong Li, et al.
China CDC Weekly (2023) Vol. 5, Iss. 17, pp. 369-373
Open Access | Times Cited: 73
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022
Xinhua Chen, Xuemei Yan, Kaiyuan Sun, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2800-2807
Open Access | Times Cited: 64
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
Divya Teli, Pankti C. Balar, Kishan Patel, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 25
Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study
Zhuoying Huang, Shuangfei Xu, Jiechen Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Real-world effectiveness of primary series and booster doses of inactivated COVID-19 vaccine against Omicron BA.2 variant infection in China: a retrospective cohort study
Lin Tang, Fuzhen Wang, Lance E. Rodewald, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 3, pp. 261-269
Open Access | Times Cited: 16
Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai
Qianhui Wu, Hongyu Wang, Jianpeng Cai, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
Luca Scarsella, Eric Ehrke‐Schulz, Michael Paulussen, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 377-377
Open Access | Times Cited: 5
Effectiveness and coverage of COVID-19 vaccination among the infection-naive population: A community-based retrospective cohort study in China
Yaqun Fu, Zhihu Xu, Quan Wang, et al.
Vaccine (2025) Vol. 50, pp. 126836-126836
Open Access
Effectiveness of mass vaccination for prevention of hospitalization, severe disease and death due to SARS-CoV-2 omicron Ba.2 variant; a case- population study
Hamid Reza Shamsollahi, Sobhan Younesian, Ali Nikfarjam, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42670-e42670
Open Access
Protection afforded by post-infection SARS-CoV-2 vaccine doses: A cohort study in Shanghai
Bo Zheng, Bronner P. Gonçalves, Pengfei Deng, et al.
eLife (2025) Vol. 13
Open Access
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 12
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System
Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case–control study
Xiaqing Zhang, Yao Wang, Cheng‐Yang Hu, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era
Tingting Zhang, Weiwei Tian, Shuang Wei, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov
Shenyu Wang, Wenqing Liu, Yuqing Li, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 704-713
Open Access | Times Cited: 10
Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts
Ting Zeng, Yaoqin Lu, Yanji Zhao, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level
Jinxin Zheng, Shan Lv, Li-Guang Tian, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Vaccines reduced hospital length of stay and fraction of inspired oxygen of COVID-19 patients: A retrospective cohort study
Xiaomei Fang, Guofang Tao, Hua Zhou, et al.
Preventive Medicine Reports (2024) Vol. 39, pp. 102632-102632
Open Access | Times Cited: 2
Evolution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: ascopingreview protocol
Paulina Stehlik, Caroline Dowsett, Ximena Camacho, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e079071-e079071
Open Access | Times Cited: 2
Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study
Dan Zhao, Ying Sun, Juan Li, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection
Fuzhen Wang, Baoying Huang, Yao Deng, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Vaccinate with Confidence and Finish Strong
Lance E. Rodewald, Dan Wu, Zundong Yin, et al.
China CDC Weekly (2022) Vol. 4, Iss. 37, pp. 828-831
Open Access | Times Cited: 11
An Observational Prospective Cohort Study of Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection of an Aerosolized, Inhaled Adenovirus Type 5–Vectored Coronavirus Disease 2019 Vaccine Given as a Second Booster Dose in Guangzhou City, China
Fuzhen Wang, Chunhuan Zhang, Lin Tang, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 1, pp. 117-121
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top